Anne‐Lise Børresen‐Dale

77.1k total citations · 6 hit papers
190 papers, 26.0k citations indexed

About

Anne‐Lise Børresen‐Dale is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anne‐Lise Børresen‐Dale has authored 190 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 99 papers in Cancer Research and 68 papers in Oncology. Recurrent topics in Anne‐Lise Børresen‐Dale's work include Cancer Genomics and Diagnostics (48 papers), Gene expression and cancer classification (37 papers) and Cancer-related Molecular Pathways (34 papers). Anne‐Lise Børresen‐Dale is often cited by papers focused on Cancer Genomics and Diagnostics (48 papers), Gene expression and cancer classification (37 papers) and Cancer-related Molecular Pathways (34 papers). Anne‐Lise Børresen‐Dale collaborates with scholars based in Norway, United States and Sweden. Anne‐Lise Børresen‐Dale's co-authors include Thérese Sørlie, Per Eystein Lønning, Charles M. Perou, Patrick O. Brown, David Botstein, Hilde Johnsen, Robert Tibshirani, Trevor Hastie, Stephanie Geisler and Stefanie S. Jeffrey and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Anne‐Lise Børresen‐Dale

188 papers receiving 25.4k citations

Hit Papers

Gene expression patterns of breast carcinomas distinguish... 1999 2026 2008 2017 2001 2003 2002 2012 2010 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    2001 8.3k citations Thérese Sørlie, Charles M. Perou et al. Proceedings of the National Academy of Sciences profile →
  2. Repeated observation of breast tumor subtypes in independent gene expression data sets
    2003 4.0k citations Thérese Sørlie, Andrew B. Nobel et al. Proceedings of the National Academy of Sciences profile →
  3. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
    2002 875 citations Thérese Sørlie, Charles M. Perou et al. Proceedings of the National Academy of Sciences profile →
  4. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
    2012 696 citations Anita Langerød, Mina J. Bissell et al. profile →
  5. Allele-specific copy number analysis of tumors
    2010 635 citations Ole Christian Lingjærde, Hege G. Russnes et al. Proceedings of the National Academy of Sciences profile →
  6. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays
    1999 531 citations Charles M. Perou, Thérese Sørlie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Lise Børresen‐Dale Norway 65 14.8k 12.4k 10.9k 4.5k 3.0k 190 26.0k
Hilde Johnsen Norway 17 13.6k 0.9× 13.3k 1.1× 13.3k 1.2× 4.0k 0.9× 3.4k 1.1× 26 26.5k
Jonathan R. Pollack United States 57 14.9k 1.0× 9.1k 0.7× 8.6k 0.8× 4.8k 1.1× 3.9k 1.3× 123 25.9k
Thérese Sørlie Norway 34 16.2k 1.1× 15.0k 1.2× 15.0k 1.4× 4.9k 1.1× 3.8k 1.3× 92 31.0k
John A. Foekens Netherlands 79 13.5k 0.9× 10.6k 0.9× 11.4k 1.0× 3.3k 0.7× 3.6k 1.2× 337 25.5k
Stefanie S. Jeffrey United States 51 16.6k 1.1× 14.9k 1.2× 13.8k 1.3× 4.7k 1.0× 3.9k 1.3× 138 33.6k
Lars A. Akslen Norway 67 13.8k 0.9× 11.6k 0.9× 14.0k 1.3× 3.3k 0.7× 4.4k 1.5× 314 29.1k
Joel S. Parker United States 72 16.2k 1.1× 13.2k 1.1× 11.4k 1.1× 3.5k 0.8× 4.3k 1.4× 278 29.7k
Åke Borg Sweden 75 10.3k 0.7× 6.8k 0.6× 6.9k 0.6× 5.1k 1.1× 2.1k 0.7× 275 18.7k
P. Andrew Futreal United States 71 16.9k 1.1× 9.3k 0.7× 7.8k 0.7× 4.1k 0.9× 4.9k 1.6× 291 28.0k
Jonas Bergh Sweden 73 11.2k 0.8× 11.6k 0.9× 15.6k 1.4× 3.3k 0.7× 4.9k 1.7× 521 29.1k

Countries citing papers authored by Anne‐Lise Børresen‐Dale

Since Specialization
Citations

This map shows the geographic impact of Anne‐Lise Børresen‐Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen‐Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen‐Dale more than expected).

Fields of papers citing papers by Anne‐Lise Børresen‐Dale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen‐Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen‐Dale. The network helps show where Anne‐Lise Børresen‐Dale may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen‐Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen‐Dale. A scholar is included among the top collaborators of Anne‐Lise Børresen‐Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen‐Dale. Anne‐Lise Børresen‐Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forés-Martos, Jaume, Vita Fedele, Sten Cornelissen, et al.. (2021). Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression. npj Breast Cancer. 7(1). 118–118. 6 indexed citations
2.
Geier, Oliver, Thomas Fleischer, Øystein Garred, et al.. (2019). Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data. Cancer Research. 79(16). 4293–4304. 17 indexed citations
3.
Davies, Helen, Sandro Morganella, Colin A. Purdie, et al.. (2017). Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency. Cancer Research. 77(18). 4755–4762. 76 indexed citations
4.
Alves, Cleidson P., Ipsita Dey‐Guha, Sheheryar Kabraji, et al.. (2017). AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth. Molecular Cancer Therapeutics. 17(1). 254–263. 19 indexed citations
5.
Panda, Anshuman, Surendra Kumar, Michael Seiler, et al.. (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. 7(1). 5568–5568. 32 indexed citations
6.
Sandset, Per Morten, Marie‐Christine Mowinckel, Øystein Garred, et al.. (2016). Determinants of acquired activated protein C resistance and D-dimer in breast cancer. Thrombosis Research. 145. 78–83. 6 indexed citations
7.
Tramm, Trine, Simen Myhre, Marianne Kyndi, et al.. (2014). Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort. Clinical Cancer Research. 20(20). 5272–5280. 71 indexed citations
8.
Sahlberg, Kristine Kleivi, Giulia Bottai, Bjørn Naume, et al.. (2014). A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients. Clinical Cancer Research. 21(5). 1207–1214. 186 indexed citations
9.
Silwal‐Pandit, Laxmi, Hans Kristian Moen Vollan, Suet‐Feung Chin, et al.. (2014). TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance. Clinical Cancer Research. 20(13). 3569–3580. 215 indexed citations
10.
Klajic, Jovana, Florence Busato, Hege Edvardsen, et al.. (2014). DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2 /p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors. Clinical Cancer Research. 20(24). 6357–6366. 43 indexed citations
11.
Quigley, David A., Laxmi Silwal‐Pandit, Ruth Dannenfelser, et al.. (2014). Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. Molecular Cancer Research. 13(3). 493–501. 47 indexed citations
12.
Kim, Jiyoung, René Villadsen, Thérese Sørlie, et al.. (2012). Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proceedings of the National Academy of Sciences. 109(16). 6124–6129. 95 indexed citations
13.
Borgan, Eldrid, Roy Navon, Hans Kristian Moen Vollan, et al.. (2011). Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Molecular Oncology. 5(6). 564–576. 25 indexed citations
14.
Agarwal, Roshan, Simen Myhre, Mark Carey, et al.. (2009). Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer. Clinical Cancer Research. 15(11). 3654–3662. 111 indexed citations
15.
Glynn, Sharon A., Brenda J. Boersma, Tiffany M. Howe, et al.. (2009). A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide. Clinical Cancer Research. 15(12). 4165–4173. 38 indexed citations
16.
Rønneberg, Jo Anders, Jörg Tost, Hiroko Kato Solvang, et al.. (2008). GSTP1 Promoter Haplotypes Affect DNA Methylation Levels and Promoter Activity in Breast Carcinomas. Cancer Research. 68(14). 5562–5571. 42 indexed citations
17.
Sørlie, Thérese, Charles M. Perou, Huihui Fan, et al.. (2006). Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Molecular Cancer Therapeutics. 5(11). 2914–2918. 97 indexed citations
18.
Dumeaux, Vanessa, Jostein Johansen, Anne‐Lise Børresen‐Dale, & Eiliv Lund. (2006). Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Molecular Cancer Therapeutics. 5(4). 868–876. 19 indexed citations
19.
Troester, Melissa A., Katherine A. Hoadley, Thérese Sørlie, et al.. (2004). Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer. Cancer Research. 64(12). 4218–4226. 143 indexed citations
20.
Langerød, Anita, et al.. (1999). BRCAl Screening in Patients with a Family History of Breast or Ovarian Cancer. Genetic Testing. 3(2). 223–226. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilde Johnsen Breakdown of academic impact, for papers by Jonathan R. Pollack Breakdown of academic impact, for papers by Thérese Sørlie Breakdown of academic impact, for papers by John A. Foekens Breakdown of academic impact, for papers by Stefanie S. Jeffrey Breakdown of academic impact, for papers by Lars A. Akslen Breakdown of academic impact, for papers by Joel S. Parker Breakdown of academic impact, for papers by Åke Borg Breakdown of academic impact, for papers by P. Andrew Futreal Breakdown of academic impact, for papers by Jonas Bergh
Rankless by CCL
2026